1-3 of 3
Sílvia Xargay-Torrent
Close
Sort by
Journal Articles

Notch1 Signaling in NOTCH1 -Mutated Mantle Cell Lymphoma Depends on DLL4 and Is a Potential Target for Specific Antibody Therapy

Elisabeth Höring, MD, Berta Colom Sanmarti, Silvia Xargay-Torrent, PhD, Walter E Aulitzky, MD, Heiko van der Kuip, PhD, Elias Campo, Mónica López-Guerra, PhD, Dolors Colomer, PhD
Journal: Blood
Blood (2016) 128 (22): 1846.
https://doi.org/10.1182/blood.V128.22.1846.1846
Published: 2016
Journal Articles

The Multi-Kinase Inhibitor Sorafenib Blocks Migration, BCR Survival Signals, Protein Translation and Stroma-Mediated Bortezomib Resistance in Mantle Cell Lymphoma

Silvia Xargay-Torrent, BS, Monica López-Guerra, PhD, Ifigènia Saborit-Villarroya, PhD, Laia Rosich, BS, Alba Navarro, BS, Neus Villamor, MD, PhD, Marta Aymerich, MD, PhD, Patricia Perez-Galan, PhD, Gael Roue, PhD, Elias Campo, MD, PhD, Dolors Colomer, PhD
Journal: Blood
Blood (2012) 120 (21): 1647.
https://doi.org/10.1182/blood.V120.21.1647.1647
Published: 2012
Journal Articles

The Hsp90 inhibitor IPI-504 overcomes bortezomib resistance in mantle cell lymphoma in vitro and in vivo by down-regulation of the prosurvival ER chaperone BiP/Grp78

Gaël Roué, Patricia Pérez-Galán, Ana Mozos, Mónica López-Guerra, Sílvia Xargay-Torrent, Laia Rosich, Ifigènia Saborit-Villarroya, Emmanuel Normant, Elias Campo, Dolors Colomer
Journal: Blood
Blood (2011) 117 (4): 1270–1279.
https://doi.org/10.1182/blood-2010-04-278853
Published: 2011
Includes: Supplemental data